MRWM Advisors, LLC

Position in MRK — Merck & Co., Inc.

CIK 1732949 NASHVILLE, TN

Position in MRK

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$1,083,640

+$4,880 QoQ

Shares Held

8,433

-6.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.84%

of 13F equity value

Holder Rank

#2,050

of 3,768 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

MRWM Advisors, LLC holds $4,668,454 across 5 Drug Manufacturers - General names. MRK ranks #2 (23.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	5,570	$1,401,634
2	MRK	Merck & Co., Inc. This page	8,433	$1,083,640
3	AMGN	Amgen Inc	2,970	$1,075,496
4	BMY	Bristol Myers Squibb Co	14,865	$856,521
5	GILD	Gilead Sciences, Inc.	1,988	$251,163

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,083,640	8,433	-6.0%	Shares	Sole	2026-07-29
2026-03-31	$1,078,760	8,968	+7.6%	Shares	Sole	2026-04-21
2025-12-31	$876,921	8,331	-9.1%	Shares	Sole	2026-01-26
2025-09-30	$769,638	9,170	-4.5%	Shares	Sole	2025-10-28
2025-06-30	$759,856	9,599	-1.0%	Shares	Sole	2025-08-27
2025-03-31	$870,133	9,694	+3.0%	Shares	Sole	2025-08-27
2024-12-31	$936,106	9,410	—	Shares	Sole	2025-08-27
No filing history on record for this holder in this stock.